Navigation Links
Amo Phaco Prestige

ProductsAmo Phaco Prestige
Company Diagnostic Instrument Group
Item Amo Phaco Prestige
Features The systems microprocessor instantly senses the change and adjusts the fluidics to preserve the balance, the AMO Prestige is distinguished by its user-friendly panel design and easily accessible controls.
Description The introduction of the AMO Prestige System marked an amazing achievement in Phaco technology; The combination of safety with high-performance fluidics.A.S.E.T. keeps you in complete control of fluidic conditions in the in the anterior chamber as the "smart Pump" orchestrates the reaction and interaction of the system components.
Info Diagnostic Instrument Group
Customer Service: (877) 344-8733

Related medicine products :

1. Kellan Phaco Manipulator
2. Koch Phacoemulsification Spatula - Rounded Tip w / notch
3. Thornton Phacoemulsification Spatula
4. Koch Phacoemulsification Spatula
5. BD Beaver Phaco slit blade
6. Odyssey Phacoemulsification System
7. SIStem Phacoemulsification System
8. Precisionist Phacoemulsification System
9. Photon Laser Phacoemulsification System
10. Phaco-Emulsification System
11. Compact Ultrasonic Phacoemulsification System
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products:
(Date:5/16/2008)...kard, from Griffiths School of Nursing and Midwife...the HESTA Australian Nursing Awards. , Professo...patient blood loss during testing procedures, redu...ansfusions among already ill patients. The award w...rnes Crown Entertainment complex. , Nurses rout...
(Date:5/16/2008)...on Public Service Announcement Available, RADNOR,...ition of,National Mental Health Month and Older Pe...n Council (SPC) will offer an important message to...ment. The public service,announcement developed by...o the public health problem of depression and to o...
(Date:5/16/2008)... appointment of Nomura Code Securities Limited as ...r, NEW YORK, May 16 /PRNewswire-FirstCall/ -- Med...ts, Inc. (Amex: MGT ) (the "Company"), and an,ind...Detection (CAD) and,image analysis software which ...sease, today announced the appointment of NM Roths...
(Date:5/16/2008)...16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A.,... Services, was honored by,Executive Women of New J...2008 Awards Dinner. The biennial event, held May 1...ized women of professional distinction in New,Jers...of directors at major,New Jersey-based corporation...
Breaking Medicine News(10 mins):Health News:Research talent wins national Innovation in Nursing award 2Health News:Suicide Prevention Group Delivers Much-Needed Message to Pennsylvania's Elderly 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
...ntified how depression plays an important role in ...normal heart beats in a depressed person that can ...or for increased risk of death from heart disease....ington University School of Medicine in St. Louis ...
...led sterols might help to lower your "bad" LDL cho... have been shown to block cholesterol's absorption... minimally absorbed by the intestines. The study ...the cases had high cholesterol, and 14 also had ty...
... of ancient Indian exercise and meditation for the... properties and is popularly used to relieve peopl... trauma and anxiety in patients with breast cance...Bangalore Institute of Oncology on Yoga therapy tr...
...nt found in turmeric or curry powder can prevent t... A new study had found that curcumin, a chemical ...that is required for certain forms of cancer to sp...its a protein called nuclear factor-kappa B (NF-kB...
Other Medicine News:Health News:Yoga Can Be Good For Breast Cancer Patients 2
(Date:5/15/2008)...5 /- Ergonex Pharma today,announced t... (FDA) has,granted orphan drug designation to Terg...rtension (PAH). Terguride is currently being evalu...., "The FDA,s grant of orphan drug designation to...development program by offering regulatory,clinic...
(Date:5/15/2008).../- Tigris Pharmaceuticals,Inc. annou... and,Development Agreement (CRADA) with the Nation...al and preclinical development of AFP-464, an,amin... is converted to,metabolites which bind covalently...., This is part of a four-year CRADA encompassing...
(Date:5/15/2008)...for an Antiplatelet Therapy that, Combined, with A...of Plavix/Iscover and Aspirin, According to a ...., May 15 /- Decision Resources, one ... for pharmaceutical and,healthcare issues, finds t...ovement in patient compared to Sanofi-Aventis/Bris...
(Date:5/15/2008)...er CEA Trial data reports in third quarter ...15 /- VIA Pharmaceuticals,...used on the development of,compounds for the treat...at,it has completed patient enrollment in its acut...one of three Phase 2 trials investigating VIA-2291...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 1Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 2Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 3Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 4Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 5Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 1Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 2Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 3Anesiva Raises 2445 Million in Common Stock Offering 2178 1Anesiva Raises 2445 Million in Common Stock Offering 2178 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 1Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 3
...007 - Gemin X Biotechnologies,Inc. announced today...nstrated that its lead compound, obatoclax (GX15-0...mphoma (MCL) cell lines and,primary cells from 11 ...cule specifically designed to inhibit all relevant...cancer target, thus restoring,the natural cell dea...
...celeron Pharma, Inc., a,biopharmaceutical company ...loskeletal, metabolic and cancer-related diseases,...th ACE-031 that,demonstrated the ability of the co...mal mice and in murine models of muscular,dystroph...to,increase muscle mass and strength as a potentia...
Other Medicine Technology:Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 2Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 3